Crohn's disease-induced non-alcoholic fatty liver disease (NAFLD) sensitizes for severe acute hepatitis B infection and liver failure

被引:12
|
作者
Canbay, A [1 ]
Bechmann, LP [1 ]
Best, J [1 ]
Jochum, C [1 ]
Treichel, U [1 ]
Gerken, G [1 ]
机构
[1] Univ Hosp Essen, Div Gastroenterol & Hepatol, Essen, Germany
来源
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2006年 / 44卷 / 03期
关键词
NASH; NAFLD; IBD; liver failure; Crohn's disease;
D O I
10.1055/s-2006-926502
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Non-alcoholic fatty liver disease (NAFLD) commonly is associated with chronic inflammatory bowel disease (CIBD) and usually is considered to be stable and benign. However, NAFLD - and in particular its subset, non-alcoholic steatohepatitis (NASH) - may lead to progressive liver disease. Moreover, NAFLD sensitizes the liver to injury and increases the risk of developing acute-on-chronic liver failure following a "third hit". We here present one patient with NASH, as probably induced by long-standing Crohn's disease in the absence of ethanol consumption or abuse. The patient acquired an acute HBV infection and died from complications. As based on the clinical and histological findings, Crohn's disease appears to be a risk factor for developing NAFLD and thus to contribute to the progression into NASH. In conclusion, we suggest that Crohn's disease-related NAFLD may increase the vulnerability of the liver, which indicates that patients with a known history of CIBD merit special attention.
引用
收藏
页码:245 / 248
页数:4
相关论文
共 50 条
  • [21] Liver-specific diagnostic for non-alcoholic fatty liver disease (NAFLD) - time to replace liver biopsy?
    Michel, Maurice
    Schattenberg, Joern M.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2020, 58 (12): : 1233 - 1240
  • [22] Clinical impact of sexual dimorphism in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
    Burra, Patrizia
    Bizzaro, Debora
    Gonta, Anna
    Shalaby, Sarah
    Gambato, Martina
    Morelli, Maria Cristina
    Trapani, Silvia
    Floreani, Annarosa
    Marra, Fabio
    Brunetto, Maurizia Rossana
    Taliani, Gloria
    Villa, Erica
    LIVER INTERNATIONAL, 2021, 41 (08) : 1713 - 1733
  • [23] Mitochondria in non-alcoholic fatty liver disease
    Simoes, Ines C. M.
    Fontes, Adriana
    Pinton, Paolo
    Zischka, Hans
    Wieckowski, Mariusz R.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2018, 95 : 93 - 99
  • [24] Treatment of non-alcoholic fatty liver disease
    Takei, Yoshiyuki
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 79 - 80
  • [25] Non-alcoholic fatty liver disease and diabetes
    Hazlehurst, Jonathan M.
    Woods, Conor
    Marjot, Thomas
    Cobbold, Jeremy F.
    Tomlinson, Jeremy W.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2016, 65 (08): : 1096 - 1108
  • [26] Glucocorticoids and non-alcoholic fatty liver disease
    Woods, Conor P.
    Hazlehurst, Jonathon M.
    Tomlinson, Jeremy W.
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2015, 154 : 94 - 103
  • [27] Significance of non-alcoholic fatty liver disease in Crohn's disease: A retrospective cohort study
    Sagami, Shintaro
    Ueno, Yoshitaka
    Tanaka, Shinji
    Fujita, Akira
    Hayashi, Ryohei
    Oka, Shiro
    Hyogo, Hideyuki
    Chayama, Kazuaki
    HEPATOLOGY RESEARCH, 2017, 47 (09) : 872 - 881
  • [28] Non-alcoholic fatty liver disease
    Maurice, James
    Manousou, Pinelopi
    CLINICAL MEDICINE, 2018, 18 (03) : 245 - 250
  • [29] Non-alcoholic fatty liver disease - What's new
    Roeb, Elke
    Steffen, Hans-Michael
    Bojunga, Joerg
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2016, 141 (07) : 494 - 496
  • [30] Non-alcoholic fatty liver disease-A pilot study investigating early inflammatory and fibrotic biomarkers of NAFLD with alcoholic liver disease
    Watt, Joanne
    Kurth, Mary Jo
    Reid, Cherith N. N.
    Lamont, John V. V.
    Fitzgerald, Peter
    Ruddock, Mark W. W.
    FRONTIERS IN PHYSIOLOGY, 2022, 13